Misplaced Pages

Biosplice Therapeutics, Inc. (formerly Samumed, LLC) is a private biopharmaceutical company based in San Diego, California. It was founded in 2008 by Osman Kibar.

Samumed's products in development target novel components of the Wnt signaling pathway. The company focuses on potential treatments for several diseases; its osteoarthritis program is its most advanced.

References

1. "Small-molecule therapeutics using Biosplice Therapeutics". Business Outreach. 2023-08-16. Retrieved 2024-07-06.
2. "Forbes Profile: Osman Kibar", "Forbes"
3. Herper, Matthew."Cure Baldness? Heal Arthritis? Erase Wrinkles? An Unknown Billionaire's Quest To Reverse Aging", "Forbes", May 10, 2016
4. ^ Ramsey, Lydia. "A $12 billion startup you've probably never heard wants to cure baldness and smooth out your wrinkles", "Business Insider", April 2, 2017
5. Lee, Yoolim. "Eternal Youth Is the Next Big Bet for Singapore Venture Capitalist", "Bloomberg", February 9, 2017
6. Jackson, Mandy. "ACR Notebook: Lilly's Baricitinib Differentiates On Pain, Ironwood's Duzallo Progress, Corbus Nears Phase III", "Informa Scrip", November 8, 2017"

This corporation or company article is a stub. You can help Misplaced Pages by expanding it.

• v
• t
• e

• Pharmaceutical industry
• Companies based in San Diego
• Biopharmaceutical companies
• 2008 establishments in California
• American companies established in 2008
• Company stubs